Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Moderate or Severe COVID-19”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Post-approval studies (Phase 4)Ended earlyNCT04362332
What this trial is testing

Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19

Who this might be right for
COVID-19
UMC Utrecht 25
Testing effectiveness (Phase 2)WithdrawnNCT04355676
What this trial is testing

Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19

Who this might be right for
Coronavirus Infection
Karyopharm Therapeutics Inc
Large-scale testing (Phase 3)Ended earlyNCT04952519
What this trial is testing

Efficacy of Amantadine Treatment in COVID-19 Patients

Who this might be right for
Patients With Moderate or Severe COVID-19
Noblewell 193
Testing effectiveness (Phase 2)UnknownNCT04595136
What this trial is testing

Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient

Who this might be right for
SARS-CoV-2 Infection
United Medical Specialties 60
Large-scale testing (Phase 3)Study completedNCT06585319
What this trial is testing

Pirfenidone LP or Collagen-polyvinylpyrrolidone in COVID-19

Who this might be right for
COVID 19
Materno-Perinatal Hospital of the State of Mexico 36
Testing effectiveness (Phase 2)UnknownNCT04969172
What this trial is testing

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection

Who this might be right for
COVID-19 Disease
Eli Sprecher, MD 155
Large-scale testing (Phase 3)Ended earlyNCT04344444
What this trial is testing

Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease

Who this might be right for
COVID-19
LCMC Health 22
Not applicableStudy completedNCT04657445
What this trial is testing

EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY

Who this might be right for
Olfactory and Taste Dysfunction in SARS-CoV2 Infection
University Hospital, Ioannina 100
Not applicableNo Longer AvailableNCT04358588
What this trial is testing

Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19

Who this might be right for
Coronavirus InfectionCOVID-19Pneumonia, Viral
Bellerophon
Testing effectiveness (Phase 2)Study completedNCT04363736
What this trial is testing

Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Hoffmann-La Roche 97
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Early research (Phase 1)Ended earlyNCT04762186
What this trial is testing

Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19

Who this might be right for
Moderate COVID-19-infection
Universitätsklinikum Köln 1
Testing effectiveness (Phase 2)UnknownNCT04902183
What this trial is testing

Safety and Efficacy of Exosomes Overexpressing CD24 in Two Doses for Patients With Moderate or Severe COVID-19

Who this might be right for
Covid19
Athens Medical Society 90
Very early researchWithdrawnNCT04323631
What this trial is testing

Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death

Who this might be right for
COVID-19
Rambam Health Care Campus
Testing effectiveness (Phase 2)Ended earlyNCT04458948
What this trial is testing

Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients

Who this might be right for
COVID-19
University of New Mexico 28
Testing effectiveness (Phase 2)Ended earlyNCT04373044
What this trial is testing

Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19

Who this might be right for
Symptomatic COVID-19 Infection Laboratory-Confirmed
University of Southern California 6